Related Experiment Video

Updated: Mar 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

Resisting resistance: Establishing new treatment options for CRPC patients

Shaunna Beedie1, William D Figg1

  • 1a Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health Bethesda , Maryland , USA.

Cancer Biology & Therapy
|February 2, 2016
PubMed

Insights

A study on castrate-resistant prostate cancer reveals how abiraterone works. It also found a breakdown product with potential for new prostate cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Castrate-resistant prostate cancer (CRPC) poses a significant therapeutic challenge.
  • Drug resistance mechanisms in CRPC require further elucidation.
  • Abiraterone is a key treatment, but its precise action and resistance pathways are not fully understood.

Purpose of the Study:

  • To investigate the mechanism of action of abiraterone in CRPC.
  • To identify and characterize bioactive metabolites of abiraterone.
  • To explore the therapeutic potential of abiraterone's breakdown products.

Main Methods:

  • Utilized in vitro and in vivo models of CRPC.
  • Employed biochemical assays to study enzyme activity and drug metabolism.
  • Analyzed drug concentrations and patient-derived xenografts.

Main Results:

  • Elucidated the detailed mechanism of abiraterone's anti-cancer activity.
  • Identified a novel bioactive breakdown product of abiraterone.
  • Demonstrated the efficacy of this breakdown product in preclinical models.

Conclusions:

  • Understanding abiraterone's mechanism is crucial for overcoming resistance.
  • A specific abiraterone metabolite exhibits significant anti-tumor bioactivity.
  • This metabolite represents a promising new therapeutic avenue for CRPC.
Keywords:
abirateroneenzalutamideprostate cancer▵4-abiraterone

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.0K
Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

48.1K

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K